Breaking News

Coriolis Pharma Adds Analytical Ultracentrifugation to Its Service Offerings

Expands its existing portfolio of GMP methods for the development of drug products.

Author Image

By: Charlie Sternberg

Associate Editor

Coriolis Pharma, a globally operating service provider for drug product development, analytics and manufacturing support, has introduced Analytical Ultracentrifugation (AUC) under GMP, thereby meeting the increasing demand in the pharmaceutical and biotech industry and expanding its existing portfolio of GMP methods for the development of high-quality drug products.   AUC is recognized as a powerful technique for the detailed study of macromolecules, including proteins, nucleic acids, viral ve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters